TITLE

Airway hyperresponsiveness and bronchial mucosal inflammation in T cell peptide-induced asthmatic reactions in atopic subjects

AUTHOR(S)
Ali, F. Runa; Kay, A. Barry; Larché, Mark
PUB. DATE
September 2007
SOURCE
Thorax;Sep2007, Vol. 62 Issue 9, p750
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Subjects with allergic asthma develop isolated late asthmatic reactions after inhalation of allergen-derived T cell peptides. Animal experiments have shown that airway hyperresponsiveness (AHR) is CD4+ cell-dependent. It is hypothesised that peptide inhalation produces increases in non-specific AHR and a T cell-dominant bronchial mucosal inflammatory response. Methods: Bronchoscopy, with bronchial biopsies and bronchoalveolar lavage (BAL), was performed in 24 subjects with cat allergy 6 h after aerosol inhalation of short overlapping peptides derived from Fel d 1, the major cat allergen. Biopsy specimens and BAL fluid were studied using immunohistochemistry and ELISA. Results: Twelve of the 24 subjects developed an isolated late asthmatic reaction without a preceding early (mast cell/histamine-dependent) reaction characteristic of whole allergen inhalation. These responders had Fe significant between-group differences (responders vs non-responders) in the changes (peptide vs diluent) in AHR (p=0.007) and bronchial mucosal CD3+ (p=0.005), CD4+ (p=0.006) and thymus- and activation-regulated chemokine (TARC)+ (p=0.003) but not CD8+ or CD25+ cells or eosinophils, basophils, mast cells and macrophages. The between-group difference for neutrophils was p=0.05 but with a non-significant within-group value (peptide vs diluent, responders, p =0.1 1). In BAL fluid there was a significant between- group difference in TARC (p=0.02) but not in histamine, tryptase, basogranulin, C3a or C5a, leukotrienes C4/D4/E4, prostaglandins D2 or F2α. Conclusions: Direct activation of allergen-specific airway T cells by peptide inhalation in patients with atopic asthma leads to increased AHR with local increases in CD3+ and CD4+ cells and TARC but no significant changes in eosinophils or basophil/mast cell products. These findings support previous animal experiments which showed a CD4+ dependence for AHR.
ACCESSION #
26640770

 

Related Articles

  • New immune cell raises prospect of asthma treatment.  // Australian Life Scientist;9/12/2011, p1 

    The suite of immune cells in the human body has increased by one, lending insight into immune responses such as asthma, and raising the possibility of a new treatment for chronic allergies.

  • T Cell Epitope Immunotherapy Induces a CD4+ T Cell Population with Regulatory Activity. Verhoef, Adrienne; Alexander, Clare; Kay, A. Barry; Larché, Mark // PLoS Medicine;Mar2005, Vol. 2 Issue 3, p253 

    Background: Synthetic peptides, representing CD4+ T cell epitopes, derived from the primary sequence of allergen molecules have been used to down-regulate allergic inflammation in sensitised individuals. Treatment of allergic diseases with peptides may offer substantial advantages over treatment...

  • Peptide Immunization Indicates that CD8+ T Cells are the Dominant Effector Cells in Trinitrophenyl-Specific Contact Hypersensitivity. Martin, Stefan; Lappin, Michael B.; Kohler, Jochen; Delattre, Virginie; Leicht, Cornelia; Preckel, Tobias; Simon, Jan C.; Weltzien, Hans Ulrich // Journal of Investigative Dermatology;Aug2000, Vol. 115 Issue 2, p260 

    SummaryThe identity of the effector T cell population involved in contact hypersensitivity is still questionable with evidence promoting both CD4+ or CD8+ T cells. Previous experimental studies have relied on the in vivo depletion of T cell subsets using antibody, or the use of knock-out mice...

  • Dendritic cells in allergic airway inflammation. Bharadwaj, Arpita S.; Bewtra, Againdra K.; Agrawal, Devendra K. // Canadian Journal of Physiology & Pharmacology;Jul2007, Vol. 85 Issue 7, p686 

    Dendritic cells (DCs) are primary antigen-presenting cells involved in interactions with T cells leading to the proliferation of TH1 or TH2 cell types. In asthma, predominance of TH2 cells appears to be responsible for disease pathogenesis. Differentiation of TH2 cells is driven by a variety of...

  • NKT cells have a role in human asthma. Leavy, Olive // Nature Reviews Immunology;May2006, Vol. 6 Issue 5, p340 

    Discusses research being done on CD1d-restricted natural killer T (NKT) cells. Reference to a study by O. Akbari et al published in a 2006 issue of "The New England Journal of Medicine"; Role of NKT cells in the development of allergen-induced airway hyperractivity in allergic asthma; Methods...

  • Effect of Tetracyclines on IgE Allergic Responses and Asthma. Joks, Rauno; Durkin, Helen G. // Recent Patents on Inflammation & Allergy Drug Discovery;Sep2011, Vol. 5 Issue 3, p221 

    There are no current therapies that specifically target IgE production in human allergic disease. We found that tetracyclines and chemically modified tetracyclines (CMT) that lack antibiotic activity prevent IgE production, making them ideal candidates for anti-allergy therapy. This is based on...

  • Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells. Dahl, Martin E.; Dabbagh, Karim; Liggitt, Denny; Sung Kim, Denny; Lewis, David B. // Nature Immunology;Mar2004, Vol. 5 Issue 3, p337 

    It is widely accepted that T helper type 1 (TH1) cytokines such as interferon-? (IFN-?) antagonize allergic diseases mediated by TH2 cytokines. The 'hygiene hypothesis' has also proposed that decreased childhood exposure to pathogen-derived TH1 cytokines may underlie the recent increased...

  • IP-10 as a biomarker for rhinoviral infections in asthma. Quint, Jennifer K. // Thorax;Mar2008, Vol. 63 Issue 3, p200 

    The article provides information about a study that examined the bronchial epithelial cells (BECs) from controls and patients with asthma. The BECs, obtained using bronchoscopy, were cultured and exposed to rhinovirus 16. The results showed that there was no significant difference between...

  • Blood Basophils and Histamine Levels in Patients. Jackson, James A.; Riordan, Hugh D.; Neathery, Sharon; Krier, Chad // Journal of Orthomolecular Medicine;2006 2nd Quarter, Vol. 21 Issue 2, p107 

    The article features a discussion on blood basophils and histamine levels in patients. Basophils circulate in blood and mast cells stay in the connective tissue or in the mucosal tissue. In allergies and asthma, histamine, one of the chemicals in basophils and mast cells, contributes to the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics